A detailed history of Jpmorgan Chase & CO transactions in Angiodynamics Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 663,903 shares of ANGO stock, worth $4.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
663,903
Previous 705,522 5.9%
Holding current value
$4.19 Million
Previous $5.53 Million 29.54%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$5.27 - $8.03 $219,332 - $334,200
-41,619 Reduced 5.9%
663,903 $3.9 Million
Q4 2023

Feb 12, 2024

BUY
$6.17 - $8.04 $701,572 - $914,204
113,707 Added 19.21%
705,522 $5.53 Million
Q3 2023

Nov 14, 2023

BUY
$7.02 - $10.32 $1.17 Million - $1.72 Million
167,015 Added 39.32%
591,815 $4.33 Million
Q2 2023

Aug 11, 2023

BUY
$8.29 - $11.16 $1.62 Million - $2.18 Million
195,102 Added 84.94%
424,800 $4.43 Million
Q1 2023

May 18, 2023

BUY
$9.1 - $15.48 $259,431 - $441,319
28,509 Added 14.17%
229,698 $2.38 Million
Q1 2023

May 11, 2023

SELL
$9.1 - $15.48 $1.38 Million - $2.35 Million
-151,891 Reduced 43.02%
201,189 $2.08 Million
Q4 2022

Feb 13, 2023

SELL
$12.06 - $21.55 $593,677 - $1.06 Million
-49,227 Reduced 12.24%
353,080 $4.86 Million
Q3 2022

Nov 14, 2022

BUY
$19.54 - $24.3 $674,266 - $838,520
34,507 Added 9.38%
402,307 $8.23 Million
Q2 2022

Aug 11, 2022

SELL
$17.83 - $24.49 $27,012 - $37,102
-1,515 Reduced 0.41%
367,800 $7.12 Million
Q1 2022

May 11, 2022

BUY
$20.46 - $29.16 $2 Million - $2.85 Million
97,632 Added 35.94%
369,315 $7.96 Million
Q4 2021

Feb 10, 2022

SELL
$24.35 - $30.97 $540,983 - $688,060
-22,217 Reduced 7.56%
271,683 $7.49 Million
Q3 2021

Nov 12, 2021

BUY
$23.36 - $29.2 $6.87 Million - $8.58 Million
293,900 New
293,900 $7.62 Million

Others Institutions Holding ANGO

About ANGIODYNAMICS INC


  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $247M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.